Ceera Investments LLC Sells 3,373 Shares of Cardinal Health, Inc. (NYSE:CAH)

Ceera Investments LLC cut its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 28.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,680 shares of the company's stock after selling 3,373 shares during the period. Ceera Investments LLC's holdings in Cardinal Health were worth $1,027,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. Rothschild Investment LLC raised its stake in shares of Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after acquiring an additional 79 shares during the last quarter. Private Trust Co. NA raised its stake in shares of Cardinal Health by 11.0% in the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after acquiring an additional 92 shares during the last quarter. Checchi Capital Advisers LLC raised its stake in shares of Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock worth $411,000 after acquiring an additional 93 shares during the last quarter. MWA Asset Management raised its stake in shares of Cardinal Health by 2.9% during the fourth quarter. MWA Asset Management now owns 3,324 shares of the company's stock worth $393,000 after buying an additional 95 shares during the last quarter. Finally, Transcend Capital Advisors LLC raised its stake in shares of Cardinal Health by 3.6% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company's stock worth $323,000 after buying an additional 96 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Down 0.5 %

Cardinal Health stock opened at $126.40 on Friday. The stock has a market capitalization of $30.53 billion, a PE ratio of 23.58, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The company has a 50 day moving average of $125.58 and a 200-day moving average of $118.82.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.60%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's payout ratio is 37.69%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CAH. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Bank of America raised shares of Cardinal Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. Mizuho began coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price target for the company. Argus set a $148.00 price target on shares of Cardinal Health in a research note on Tuesday, February 4th. Finally, Morgan Stanley boosted their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research note on Friday, January 31st. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.